The Battle of Biopsies: Results of a Multi-institutional Randomized Trial of Transrectal vs Transperitoneal Prostate Biopsy

Posted by Mohamad E. Allaf, MD | Oct 2024

Mohamad E. Allaf, MD, presented “The Battle of Biopsies: Results of a Multi-institutional Randomized Trial of Transrectal vs Transperitoneal Prostate Biopsy” during the 43rd Annual Ralph E. Hopkins Urology Seminar on January 31, 2024, in Jackson Hole, Wyoming.

This content is available free to the GRU Community. Login or create an account to view it.

Create an Account

How to cite: Allaf, Mohamad E. “The Battle of Biopsies: Results of a Multi-institutional Randomized Trial of Transrectal vs Transperitoneal Prostate Biopsy.” January 31, 2024. Accessed Dec 2024. https://grandroundsinurology.com/the-battle-of-biopsies-results-of-a-multi-institutional-randomized-trial-of-transrectal-vs-transperitoneal-prostate-biopsy-2/

The Battle of Biopsies: Results of a Multi-institutional Randomized Trial of Transrectal vs Transperitoneal Prostate Biopsy – Summary

Mohammed E. Allaf, MD, delivers a compelling analysis of the outcomes from a multi-institutional randomized trial comparing transrectal and transperitoneal prostate biopsy techniques. This study, which Dr. Allaf presents in detail, addresses a critical question in urological practice: which biopsy method offers the best balance between diagnostic accuracy and patient safety?

Dr. Allaf begins this 21-minute conversation by discussing the historical preference for transrectal prostate biopsy. However, he highlights the growing concerns regarding infection rates and the potential for antibiotic resistance associated with this technique. In contrast, although less commonly used, the transperitoneal approach is posited to reduce the risk of infections and complications.

About The 43rd Annual Ralph E. Hopkins Urology Seminar:

The Ralph E. Hopkins Urology Seminar is a multi-day meeting focused on training urologists in the latest in assessing, diagnosing, and treating urologic conditions in the clinical setting. Updates are provided on urologic cancers, stone disease, urologic reconstruction, female urology, infertility, sexual function, emerging surgical techniques, and general urology. The 43rd iteration of the meeting took place from January 31st to February 2nd, 2024, in Jackson Hole, Wyoming.

For further educational activities from this conference, visit our collection page.

About The Author

Mohamad E. Allaf, MD

Mohamad E. Allaf, MD, is Professor of Urology and Oncology, as well as Director of the Department of Urology and the Brady Urological Institute, Urologist-in-Chief of the Johns Hopkins Hospital, and Director of Minimally Invasive and Robotic Surgery. Dr. Allaf earned his medical degree from Johns Hopkins University, where he also completed his residency in urology. Dr. Allaf is a world renowned surgeon-scientist who has performed more than 2,000 robotic procedures and published over 250 peer reviewed research papers in the field's best journals. Dr. Allaf has used Dr. Patrick Walsh's method of radical prostatectomy as the basis for his own anatomic method to this complex operation. Dr. Allaf is also amongst the leaders in kidney cancer surgery, having served on the American Urological Association (AUA) Guideline Committee for Kidney Cancer. He led a team who performed the rigorous analysis to help inform the most recent guidelines that was funded by the Agency for Healthcare Research and Quality (AHRQ). He is best known for his ability to save the kidney and remove the tumor in patients with kidney tumors. Dr. Allaf runs a research endeavor aiming to decrease the morbidity associated with the treatment of cancer, and he has mentored numerous leaders in academic urology. He is actively involved in fundraising for research and education, and believes in expanding the base of support in order to advance this important mission.

Join the GRU Community

- Why Join? -

Share This

Chat with usLiveChat